A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan I… (NCT02307175) | Clinical Trial Compass
CompletedNot Applicable
A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication
Canada30 participantsStarted 2014-09-01
Plain-language summary
Prospective, open label single site study to demonstrate the safety and efficacy of Tc-99m pertechnetate produced by high energy cyclotron at CHUS.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Prescribed thyroid scan
* Provided written informed consent prior to participation
* Biochemical parameters within 5 times of the normal limits for age
* WBC count \> 3.0/μL
* ANC count 1.5/μL
* Platelets \> 75,000/μL
* Haemoglobin \> 10 g/dL
* Karnofsky Performance Scale score \> 50
Exclusion Criteria:
* Nursing or pregnant females
* Biochemical parameters as measured outside 5 times the normal limits for age within 14 days of the scan
* WBC \< 3.0/μL
* ANC \< 1.5/μL
* Platelets \< 75,000/μL
* Haemoglobin \< 10 g/dL
* Unable and unwilling to follow instructions and comply with the protocol
* Unable or unwilling to provide written informed consent prior to participation in the study
* Karnofsky Performance Scale score \< 50
What they're measuring
1
Biodistribution of Tc99m produced by high-energy cyclotron (CycloTec)
Timeframe: 6 months
Trial details
NCT IDNCT02307175
SponsorCentre de recherche du Centre hospitalier universitaire de Sherbrooke